West Pharmaceutical Services stock sank Thursday after the company issued a full-year outlook that missed analysts’ ...

Royalty Pharma's Q4 results show portfolio receipts of $742 million and operating cash flow of $678 million. Read why RPRX ...

PM; the BSE Smallcap and BSE Midcap indices were down 3.1% and 2.3%, respectively, as against 0.3% decline in the BSE Sensex.

Avadel Pharmaceuticals' stock is undervalued due to peak sales potential, along with the possibility of a buyout. Click here ...

State of Alaska Department of Revenue cut its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 25.6% during the 4th quarter, according to the company in its most ...

StockNews.com lowered shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a hold rating to a sell rating in a ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Stock analysis and recommendations for Glenmark Pharmaceuticals, Nippon Life India Asset Management and SRF with potential ...

A world where hospitals never run out of critical medicines, retail stores always have the right seasonal products in stock, ...

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.